Skip to main content

Milestone 9.H

Launch research programs to develop and validate sensitive neuropsychological and behavioral assessment measures to detect and track the earliest clinical manifestations of AD and AD-related dementias.


Success Criteria

  • Development of at least one sensitive neuropsychological assessment measure that has been validated for the detection or tracking of the earliest clinical manifestations of AD and AD-related dementias.

  • Extend ongoing research on social and emotional functioning and decision-making in MCI/AD to identify early behavioral markers of disease.

  • Support research to develop clinical tools for assessment of early deficits in decision-making, motivation and social and emotional functioning in AD.


Research Implementation Area
Biomarkers
Timeline
2014–2022
Status
Complete

Implementation Activities

Funding Initiatives

Research Programs and Resources

Research Highlights

Relevant Recommendations